News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Drug Development
ImClone Systems Incorporated Says Its Cancer Drug Works as Initial Treatment
June 20, 2008
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
CHICAGO — Two biotechnology giants did battle here at the nation’s largest cancer conference over the weekend. And both remained standing.
Twitter
LinkedIn
Facebook
Email
Print
Clinical research
Phase 3
MORE ON THIS TOPIC
Earnings
Moderna maintains 10% growth target despite Phase 3 norovirus miss
July 31, 2026
·
4 min read
·
Gabrielle Masson
FDA
Replimune overcomes ‘messy data’ to secure positive adcomm vote for melanoma therapy
July 30, 2026
·
5 min read
·
Michael Gibney
Earnings
BMS’ ‘big beat’ clouded by Cobenfy, heart disease data delays
July 30, 2026
·
4 min read
·
Gabrielle Masson
Earnings
Regeneron’s ‘aversion’ to M&A questioned as bumper Q2 builds war chest
July 30, 2026
·
2 min read
·
Nick Paul Taylor